---
$id: https://graph.org.ai/products/commodity/51323105
$type: Product
source: UNSPSC
code: "51323105"
title: "Disogluside"
class: "51323100"
classTitle: "Antihyperlipidemics and hypocholesterolemics, synthesized"
family: "51320000"
familyTitle: "Antihyperlipidemic and hypocholesterolemic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Disogluside

**UNSPSC Code**: 51323105
**Class**: [Antihyperlipidemics and hypocholesterolemics, synthesized](Antihyperlipidemics and hypocholesterolemics, synthesized.mdx)
**Family**: [Antihyperlipidemic and hypocholesterolemic agents](../Antihyperlipidemic and hypocholesterolemic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-lipidemic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8KI671F2NS. European Medicines Agency schedules Disogluside in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07236MIG. Disogluside generally arises in the molecular formula C33H52O8. The term DISOGLUSIDE is an International Non-Proprietary Name or INN. DISOGLUSIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule disogluside under HS 29389090 and SITC 54161. As of Q4 2014, DISOGLUSIDE remains the US FDA Preferred Term for this commodity. Disogluside bears US NLM identifiers UMLS ID C2699784 and NCI Concept Code C78057. SMILES: O1C2C(C3(C(C4C(CC3)C3(C(=CC4)CC(OC4OC(C(O)C(O)C4O)CO)CC3)C)C2)C)C(C21OCC(CC2)C)C.

